Lyra Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
OTC.Pink
Perceptive Advisors and its affiliates have fully divested their beneficial ownership in Lyra Therapeutics, Inc., ceasing to be a 5% shareholder.
OTC.Pink
Perceptive Advisors and its affiliates have reduced their beneficial ownership in Lyra Therapeutics, Inc. to 5.5% through recent share sales.
OTC.Pink
Perceptive Advisors and its affiliates have reduced their beneficial ownership in Lyra Therapeutics, Inc. to 7.8% through recent share sales.
OTC.Pink
Perceptive Advisors and its affiliates have significantly reduced their beneficial ownership in Lyra Therapeutics, Inc. to 11.2% through recent share sales.
OTC.Pink
Perceptive Advisors and affiliates updated their beneficial ownership in Lyra Therapeutics, Inc., now holding 15.55% of common stock.